Sabra Healthcare REIT (NASDAQ:SBRA) Hits New 12-Month High – What’s Next?

Posted by Geri Gentry on May 15th, 2026

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Get Free Report) reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $21.09 and last traded at $20.8910, with a volume of 105726 shares. The stock had previously closed at $20.97.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Wall Street Zen lowered shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Sunday, May 10th. Cantor Fitzgerald raised their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Monday. Truist Financial lifted their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research report on Friday, March 13th. UBS Group boosted their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Wednesday. Finally, Citigroup increased their price objective on Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, February 18th. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $22.20.

Read Our Latest Analysis on SBRA

Sabra Healthcare REIT Price Performance

The firm has a market capitalization of $5.35 billion, a PE ratio of 33.65, a P/E/G ratio of 1.69 and a beta of 0.67. The firm’s fifty day moving average price is $20.28 and its 200 day moving average price is $19.51. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last issued its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The firm had revenue of $221.75 million during the quarter, compared to analysts’ expectations of $209.20 million. During the same quarter last year, the company posted $0.37 earnings per share. The firm’s revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities analysts forecast that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 29th. Stockholders of record on Friday, May 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.7%. The ex-dividend date of this dividend is Friday, May 15th. Sabra Healthcare REIT’s payout ratio is 190.48%.

Institutional Trading of Sabra Healthcare REIT

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its holdings in Sabra Healthcare REIT by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 35,430,016 shares of the real estate investment trust’s stock valued at $671,045,000 after acquiring an additional 481,231 shares during the period. Principal Financial Group Inc. increased its holdings in shares of Sabra Healthcare REIT by 0.4% during the 1st quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust’s stock valued at $481,755,000 after purchasing an additional 98,770 shares in the last quarter. Nuveen LLC increased its holdings in shares of Sabra Healthcare REIT by 28.6% during the 4th quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock valued at $138,324,000 after purchasing an additional 1,625,072 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Sabra Healthcare REIT by 2.9% in the 4th quarter. Geode Capital Management LLC now owns 7,018,556 shares of the real estate investment trust’s stock valued at $132,949,000 after purchasing an additional 198,118 shares during the period. Finally, Bank of America Corp DE lifted its stake in shares of Sabra Healthcare REIT by 9.4% in the 3rd quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock valued at $97,378,000 after purchasing an additional 447,528 shares during the period. 99.40% of the stock is owned by institutional investors and hedge funds.

About Sabra Healthcare REIT

(Get Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.